Surgically treated reactive arthritis of the ankle after COVID-19 infection: A case report

Shimoyama, Kohei; Teramoto, Atsushi; Murahashi, Yasutaka; Takahashi, Katsunori; Watanabe, Kota; Iba, Kousuke; Yamashita, Toshihiko

doi:10.1016/j.jiac.2021.12.028

Cited by 11 publications

(26 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The overwhelming majority of patients did not have a personal history of preexisting joint symptoms or autoimmune disease. Pertinent comorbidities included preexisting RA in one of the cases described by Alivernini et al 9 as well as one of the cases described by Derksen et al, 17 gout with recurrent acute arthritis in three of the cases described by Lopez-Gonzalez et al, 29 gout in each of the cases described by Ouedraogo et al 35 and Shimoyama et al, 40 unspecified recurrent acute arthritis in one of the cases described by Lopez-Gonzalez et al, 29 remote history of septic arthritis in one of the cases described by Sinaei et al, 42 chronic intermittent monoarticular joint pain in the case described by Kuschner et al, 27 sarcoidosis in one of the cases described by Derksen et al, 17 and autoimmune hypothyroidism in two cases described by Colatutto et al. 14 A comprehensive list of the comorbidities reported for each patient can be found in Table 1 .…”

Section: Resultsmentioning

confidence: 96%

“… 31 , 40 Neves et al 31 inserted a drainage catheter in a patient presenting with presumed septic arthritis with intramuscular collections with joint continuity noted on imaging. Shimoyama et al 40 performed arthroscopic synovectomy in a patient with reactive arthritis that was unresponsive to a trial of NSAIDs and intraarticular steroid injection. It is important to note that most reports lacked details regarding treatment duration.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

et al. 2022

View full text Add to dashboard Cite

Background Given the widespread impact of COVID-19, it is important to explore any atypical presentations and long-term sequelae associated with this viral infection, including the precipitation of inflammatory arthritis. Objective To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19. Methods A systematic review of the PubMed (MEDLINE), Google Scholar, and Cochrane Central databases through January 31, 2022 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The inclusion criteria were: human subjects and English language. Data extraction and qualitative synthesis of the demographics, clinical presentations, treatments, and outcomes were performed. Quality assessment was performed using the Joanna-Briggs Institute critical appraisal tools. Results A total of 37 articles collectively describing the cases of 54 patients were included. The mean age was 48.2 years (6-78 years). 53.7% of patients were male and 46.3% were female. The onset of articular symptoms varied considerably, and the majority of cases were described as polyarticular (29). The classification of inflammatory arthritis in the included studies was as follows: reactive (19), post-viral (13), new-onset rheumatoid arthritis (RA) (8), crystal-proven arthropathy flare (4), acute viral (2), new-onset psoriatic arthritis (2), flare of preexisting RA (2), and other (4). Arthritis treatment regimens varied but consisted largely of NSAIDs and corticosteroids with most patients experiencing improvement or resolution of their joint symptoms. Conclusion There is limited low-level evidence suggesting that patients may develop acute arthritis during or after SARS-CoV-2 infection. This review highlights the need for further research to elucidate the relationship between COVID-19 and the development of inflammatory arthritis.

show abstract

Section: Resultsmentioning

confidence: 96%

Section: Resultsmentioning

confidence: 99%

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

et al. 2022

View full text Add to dashboard Cite

show abstract

“…COVID-19 chest computed tomography images such as ground glass opacities may resemble rheumatologic SAD including SLE and RA with extensive lung involvement, making the diagnosis of viral infection challenging [ 135 ]. Due to inflammation, bone erosion leading to rheumatoid nodules may be detected [ 136 ], and viral SARS-Cov2 RNA retrieved in the synovial fluid [ 137 , 138 ]. The shift from reactive arthritis following COVID-19 infection to RA remains exceptional, which supports the possibility that additional genetic and environmental factors are required (Arleevskaya et al, 2021).…”

Section: Sars-cov-2/covid19 Vaccination and Autoimmune And Chronic In...mentioning

confidence: 99%

SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

Larionova

Byvaltsev

Кравцова

et al. 2022

Journal of Translational Autoimmunity

View full text Add to dashboard Cite

“…This could be related to early stages of disease or because medications used to treat other manifestations of COVID-19, such as corticosteroids or hydroxychloroquine, may blunt the severity of the synovitis ( 10 ). The presence of erosions may suggest an underlying rheumatologic disease such as RA ( 34 ). Similarly, US can help detect synovial thickening, which may be heterogeneous or hypoechoic relative to other tissues.…”

Section: Covid-19 In Msk Systemmentioning

confidence: 99%

Musculoskeletal Manifestations of COVID-19: Currently Described Clinical Symptoms and Multimodality Imaging Findings

Omar¹,

Weaver²,

Samet³

et al. 2022

RadioGraphics

View full text Add to dashboard Cite

COVID-19, the clinical syndrome produced by infection with SARS-CoV-2, can result in multisystem organ dysfunction, including respiratory failure and hypercoagulability, which can lead to critical illness and death. Musculoskeletal (MSK) manifestations of COVID-19 are common but have been relatively underreported, possibly because of the severity of manifestations in other organ systems. Additionally, patients who have undergone sedation and who are critically ill are often unable to alert clinicians of their MSK symptoms. Furthermore, some therapeutic measures such as medications and vaccinations can worsen existing MSK symptoms or cause additional symptoms. Symptoms may persist or occur months after the initial infection, known as post-COVID condition or long COVID. As the global experience with COVID-19 and the vaccination effort increases, certain patterns of MSK disease involving the bones, muscles, peripheral nerves, blood vessels, and joints have emerged, many of which are likely related to a hyperinflammatory host response, prothrombotic state, or therapeutic efforts rather than direct viral toxicity. Imaging findings for various COVID-19–related MSK pathologic conditions across a variety of modalities are being recognized, which can be helpful for diagnosis, treatment guidance, and follow-up. The online slide presentation from the RSNA Annual Meeting is available for this article. © RSNA, 2022

show abstract

Surgically treated reactive arthritis of the ankle after COVID-19 infection: A case report

Cited by 11 publications

References 14 publications

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

Musculoskeletal Manifestations of COVID-19: Currently Described Clinical Symptoms and Multimodality Imaging Findings

Contact Info

Product

Resources

About